Search for other papers by Michelle J Galvan in
Google Scholar
PubMed
Search for other papers by Michael J Sanchez in
Google Scholar
PubMed
Australian Institute for Musculoskeletal Science (AIMSS), Victoria University, Melbourne, Victoria, Australia
Search for other papers by Andrew J McAinch in
Google Scholar
PubMed
Search for other papers by Jeffrey D Covington in
Google Scholar
PubMed
Search for other papers by Jason B Boyle in
Google Scholar
PubMed
Search for other papers by Sudip Bajpeyi in
Google Scholar
PubMed
dramatic increase in obesity, insulin resistance, and type 2 diabetes mellitus (T2DM) ( 2 ). Adherence is further challenging for those with obesity and T2DM suffering from defects in lipid oxidation capacity, musculoskeletal pain, and peripheral neuropathy
Search for other papers by Valentina Guarnotta in
Google Scholar
PubMed
Search for other papers by Silvia Lucchese in
Google Scholar
PubMed
Search for other papers by Mariagrazia Irene Mineo in
Google Scholar
PubMed
Search for other papers by Donatella Mangione in
Google Scholar
PubMed
Search for other papers by Renato Venezia in
Google Scholar
PubMed
Search for other papers by Piero Luigi Almasio in
Google Scholar
PubMed
Search for other papers by Carla Giordano in
Google Scholar
PubMed
) ( 1 , 2 ). Insulin resistance with total, visceral, and hepatic adiposity is thought to be a major driver of such early maturation ( 3 , 4 ). Non-classical congenital adrenal hyperplasia or heterozygous carriers of 21-hydroxylase deficiency can
Search for other papers by Aline Stangherlin Martins in
Google Scholar
PubMed
Search for other papers by Ann Kristine Jansen in
Google Scholar
PubMed
Search for other papers by Luiz Oswaldo Carneiro Rodrigues in
Google Scholar
PubMed
Search for other papers by Camila Maria Matos in
Google Scholar
PubMed
Search for other papers by Marcio Leandro Ribeiro Souza in
Google Scholar
PubMed
Search for other papers by Juliana Ferreira de Souza in
Google Scholar
PubMed
Search for other papers by Maria de Fátima Haueisen Sander Diniz in
Google Scholar
PubMed
Search for other papers by Sandhi Maria Barreto in
Google Scholar
PubMed
Search for other papers by Leonardo Mauricio Diniz in
Google Scholar
PubMed
Neurofibromatosis Outpatient Reference Center, Department of Nutrition, Federal University of Minas Gerais, Department of Medical Clinic, Federal University of Minas Gerais, Department of Preventive and Social Medicine, Federal University of Minas Gerais, Department of Internal Medicine, Federal University of Minas Gerais, The Neurofibromatosis Institute, Federal University of Minas Gerais, Alameda Álvaro Celso 55, Belo Horizonte, Minas Gerais, Brazil
Search for other papers by Nilton Alves de Rezende in
Google Scholar
PubMed
Search for other papers by Vincent Michael Riccardi in
Google Scholar
PubMed
previous studies (6, 8) . Both type 1 and type 2 DM contribute to development of VD (12) . Type 1 DM is associated with an inadequate availability of insulin and usually manifests in childhood, whereas type 2 DM is related to insulin resistance and
Search for other papers by E N Dudinskaya in
Google Scholar
PubMed
Search for other papers by O N Tkacheva in
Google Scholar
PubMed
Search for other papers by M V Shestakova in
Google Scholar
PubMed
Search for other papers by N V Brailova in
Google Scholar
PubMed
Search for other papers by I D Strazhesko in
Google Scholar
PubMed
Search for other papers by D U Akasheva in
Google Scholar
PubMed
Search for other papers by O Y Isaykina in
Google Scholar
PubMed
Search for other papers by N V Sharashkina in
Google Scholar
PubMed
Search for other papers by D A Kashtanova in
Google Scholar
PubMed
Search for other papers by S A Boytsov in
Google Scholar
PubMed
ageing and the development of age-related diseases. In addition, insulin resistance (IR) is considered to be a predictor of atherosclerosis and CVD independently of other risk factors, such as blood lipid levels, and hyperglycaemia results in ageing
Search for other papers by Nafiye Helvaci in
Google Scholar
PubMed
Search for other papers by Erdem Karabulut in
Google Scholar
PubMed
Search for other papers by Ahmet Ugur Demir in
Google Scholar
PubMed
Search for other papers by Bulent Okan Yildiz in
Google Scholar
PubMed
fully understood, obesity, insulin resistance and hyperandrogenemia, which are the main features of PCOS, are all proposed to play a role in the development of OSA in patients with PCOS. The objective of this meta-analysis was to examine if there is an
2nd Department of Internal Medicine, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University in Prague, Srobarova, Prague, Czech Republic
Search for other papers by T Grimmichova in
Google Scholar
PubMed
Diabetes Centre, Institute for Clinical and Experimental Medicine (IKEM), Videnska, Prague, Czech Republic
Search for other papers by M Haluzik in
Google Scholar
PubMed
Search for other papers by K Vondra in
Google Scholar
PubMed
Search for other papers by P Matucha in
Google Scholar
PubMed
Search for other papers by M Hill in
Google Scholar
PubMed
ultrasound-guided fine-needle aspiration ( 6 ). Finally, and the topic of our study, (8) type 2 diabetes (T2DM), obesity and insulin resistance (IR) in the framework of the worldwide epidemic of diabetes and obesity. In general, patients with diabetes have an
Search for other papers by Liza Haqq in
Google Scholar
PubMed
Search for other papers by James McFarlane in
Google Scholar
PubMed
Search for other papers by Gudrun Dieberg in
Google Scholar
PubMed
Search for other papers by Neil Smart in
Google Scholar
PubMed
hyperandrogenism (clinical manifestations are hirsutism, android alopecia and acne), oligo/amenorrhoea (infrequent or no menstruation), polycystic ovaries and infertility or reduced fertility (3, 4) . Often women with PCOS are obese, which contributes to insulin
Department of Medicine, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland
Search for other papers by Selina Mäkinen in
Google Scholar
PubMed
Department of Medicine, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland
Search for other papers by Neeta Datta in
Google Scholar
PubMed
Department of Medicine, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland
Search for other papers by Yen H Nguyen in
Google Scholar
PubMed
Department of Medicine, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland
Search for other papers by Petro Kyrylenko in
Google Scholar
PubMed
Search for other papers by Markku Laakso in
Google Scholar
PubMed
Department of Medicine, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland
Search for other papers by Heikki A Koistinen in
Google Scholar
PubMed
simvastatin was most likely involved in muscular adverse effects ( 12 ). The mechanisms whereby statins affect insulin sensitivity in human muscle are unclear. Simvastatin-induced insulin resistance has been proposed to result from decreased lipid synthetic
University of Helsinki, Department of Medicine, and Abdominal Center, Endocrinology, Helsinki University Central Hospital, Helsinki, Finland
Search for other papers by Selina Mäkinen in
Google Scholar
PubMed
University of Helsinki, Department of Medicine, and Abdominal Center, Endocrinology, Helsinki University Central Hospital, Helsinki, Finland
Search for other papers by Yen H Nguyen in
Google Scholar
PubMed
University of Helsinki, Department of Medicine, and Abdominal Center, Endocrinology, Helsinki University Central Hospital, Helsinki, Finland
Search for other papers by Paulina Skrobuk in
Google Scholar
PubMed
University of Helsinki, Department of Medicine, and Abdominal Center, Endocrinology, Helsinki University Central Hospital, Helsinki, Finland
Search for other papers by Heikki A Koistinen in
Google Scholar
PubMed
Introduction Excess dietary fat and sedentary lifestyle predispose to insulin resistance and type 2 diabetes. As skeletal muscle accounts for 80% of glucose disposal under insulin-stimulated conditions ( 1 , 2 ), it is an important target
Search for other papers by Nese Cinar in
Google Scholar
PubMed
Search for other papers by Alper Gurlek in
Google Scholar
PubMed
ADP, vaspin, and visfatin in the context of thyroid dysfunction and the associated changes in adipose tissue and insulin resistance. The reason for choosing them is the increasing evidence regarding their changes in states of thyroid dysfunction